Idiopathic Pulmonary Fibrosis and Antifibrotic Treatments: Focus on Experimental Studies

Archives of Pathology & Laboratory Medicine
Francesca LunardiFiorella Calabrese

Abstract

- Idiopathic pulmonary fibrosis (IPF) is a progressive fatal disease that up to now has been associated with a poor outcome. Some advances have been made in understanding the multiple interrelated pathogenic pathways underlying IPF. The disease is now believed to result from complex interactions among genetic, epigenetic, transcriptional, posttranscriptional, metabolic, and environmental factors. The discovery and validation of theranostic biomarkers are necessary to enable a more precise and earlier diagnosis of IPF and to improve the prediction of future disease behavior. Two drugs recently approved by the US Food and Drug Administration, pirfenidone and nintedanib, have shown the ability to reduce the progression of the disease, although survival benefits are only minimal and neither drug prevents or reverses the disease. - To provide a critical overview of the main experimental studies carried out for testing the principal effects of pirfenidone and nintedanib on IPF. - Experimental (animal and in vitro) studies concerning both drugs were used. - Pirfenidone has a longer history of preclinical experimental studies than nintedanib. Many studies have been reported more recently (after 2014) and some of them evaluated the asso...Continue Reading

References

Feb 7, 1997·Toxicology Letters·J P Kehrer, S B Margolin
Apr 4, 1998·American Journal of Respiratory Cell and Molecular Biology·G GurujeyalakshmiS N Giri
Jul 2, 2003·Toxicological Sciences : an Official Journal of the Society of Toxicology·Jeffrey W CardThomas E Massey
Aug 6, 2004·The European Respiratory Journal·T KakugawaS Kohno
Jan 25, 2005·American Journal of Respiratory and Critical Care Medicine·Arata AzumaShoji Kudoh
May 13, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Hanzhong LiuGary A Visner
Feb 16, 2007·The European Respiratory Journal·N I ChaudharyJ E Park
Dec 10, 2009·The European Respiratory Journal·H TaniguchiUNKNOWN Pirfenidone Clinical Study Group in Japan
Apr 8, 2011·American Journal of Respiratory and Critical Care Medicine·Ganesh RaghuUNKNOWN ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis
May 17, 2011·Lancet·Paul W NobleUNKNOWN CAPACITY Study Group
Jul 2, 2011·Lancet·Talmadge E KingMoisés Selman
Oct 14, 2011·The New England Journal of Medicine·Luca RicheldiRoland M du Bois
Aug 29, 2012·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Soroush SeifiradAlireza Ghaffari
Feb 5, 2013·Biochimica Et Biophysica Acta·Richard P MarshallPauline T Lukey
Feb 22, 2014·The Journal of Pharmacology and Experimental Therapeutics·Lutz WollinBernhard Ryffel
Mar 13, 2014·International Journal of Pharmaceutics·Robert F H WalterLutz Freitag
Mar 13, 2014·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Enrico ConteCarlo Vancheri
May 20, 2014·The New England Journal of Medicine·Fernando J MartinezGanesh Raghu
May 20, 2014·The New England Journal of Medicine·Luca RicheldiUNKNOWN INPULSIS Trial Investigators
May 20, 2014·The New England Journal of Medicine·Talmadge E KingUNKNOWN ASCEND Study Group
Jul 17, 2014·American Journal of Respiratory Cell and Molecular Biology·Yasmina BauerNaftali Kaminski
Dec 17, 2014·Pharmacology Research & Perspectives·Joanne Porte, Gisli Jenkins
Jun 4, 2015·American Journal of Respiratory and Critical Care Medicine·Claudia A Staab-WeijnitzOliver Eickelberg
Jun 16, 2015·American Journal of Respiratory Cell and Molecular Biology·Sunad RangarajanVictor J Thannickal
Jul 16, 2015·American Journal of Respiratory and Critical Care Medicine·Ganesh RaghuUNKNOWN Latin American Thoracic Association
May 31, 2016·Pulmonary Pharmacology & Therapeutics·Tommaso NeriAlessandro Celi
Feb 6, 2017·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Miroslava DidiasovaMalgorzata Wygrecka
Mar 4, 2017·American Journal of Respiratory Cell and Molecular Biology·Larissa KnüppelClaudia A Staab-Weijnitz
Mar 12, 2017·Angiogenesis·Maximilian AckermannMoritz A Konerding
May 2, 2017·American Journal of Respiratory Cell and Molecular Biology·R Gisli JenkinsUNKNOWN ATS Assembly on Respiratory Cell and Molecular Biology

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Related Papers

Advanced Drug Delivery Reviews
Aswin SundarakrishnanDavid L Kaplan
American Journal of Respiratory and Critical Care Medicine
Jason RajchgotAnju Anand
© 2022 Meta ULC. All rights reserved